Skip to content

Anterix ATEX Spectrum receivable

Spectrum receivable at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$3.98M+78.9%
Ardelyx logo
ArdelyxARDX
$15M
Douglas Emmett logo
Douglas EmmettDEI
$126.54M+6.0%
Marcus & Millichap logo
Marcus & MillichapMMI
$12.75M-5.3%
Vornado Realty logo
Vornado RealtyVNO
$778.7M+9.5%
Crown Castle logo
Crown CastleCCI
$179M-3.2%

Other financials

Income statement

See full
Revenue$2.0M+41.0%
Gross profit$608.0K+81.5%
Operating income$19.8M
Net income$18.5M
EPS (diluted)$0.98

Balance sheet

See full
Cash & equivalents$98.5M+108%
Total debt$4.4M-18.0%
Total equity$262.3M+67.5%
Total assets$465.2M+39.7%

Cash flow

See full
Operating cash flow$15.5M+194%
CapEx$22.0K-52.2%
Free cash flow$15.5M+193%

Valuation

See full
Market cap$1.5B+190%
Enterprise value$1.4B+196%
P/E16.5×
P/S230.1×+145×

Profitability

See full
Gross margin-105.3%
Operating margin1,444.9%
Net margin1,394.2%
FCF margin-486.7%-1,481pp

Returns & leverage

See full
Return on equity43.3%
Debt / equity0.0×
Current ratio3.3×+1.1×

Where this comes from

Reported directly by Anterix in its filing.

Tagged under the XBRL concept atex:SpectrumReceivableCostsCurrent.

The official record: Anterix’s 10-K, filed June 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anterix's spectrum receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anterix's spectrum receivable?
Anterix (ATEX) reported spectrum receivable of $10.64M in Q1 2026.
How has Anterix's spectrum receivable changed year-over-year?
Anterix's spectrum receivable increased by 49.7% year-over-year, from $7.11M to $10.64M.
What is the long-term trend for Anterix's spectrum receivable?
Over 3 years (2023 to 2026), Anterix's spectrum receivable has grown at a -8.4% compound annual growth rate (CAGR), from $13.83M to $10.64M.
What does spectrum receivable mean?
This represents the current portion of receivables specifically tied to the licensing, leasing, or sale of spectrum assets. It reflects the near-term cash expected from the monetization of wireless communication rights. Tracking this is essential for evaluating the liquidity generated from the company's core spectrum-based business model.